Monday 9 November 2009

READ THE NEWS ON ONE CLICK
http://www.theoneclickgroup.co.uk

1.  
Poland Prime Minister Slams Drug Companies Over Swine Flu Vaccine

Poland's Prime Minister Donald Tusk on Friday slammed drug companies selling swine flu vaccines for allegedly refusing to take legal responsibility for any of their possible side effects.
"We know that the companies offering H1N1 vaccines don't want to take responsibility for (the) side effects," Tusk told reporters Friday in Warsaw. "Today we are dealing with huge pressure from pharmaceutical companies. The zealousness of certain countries in administering the vaccine seems exaggerated and out of step with the real epidemic. Poland wants certainty that A(H1N1) vaccines are - safe from the point of view of Polish patients."
JAVNO

2. 
Italian Physicians Refuse Swine Flu Vaccine For Patients

Italian family physicians refuse to prescribe the A/H1N1 vaccine for their patients, claiming that the risks of the vaccine outweigh its benefits. Italian media outlets claimed that many of the 48 million doses of the A/H1N1 vaccine ordered would be useless as the majority of Italians including the Deputy Health Minister Ferruccio Fazio and the Mayor of Rome Gianni Alemanno have decided against vaccination. A member of the European Association for Quality in General Medicine(EQUIP), Gianluigi Passerini told L'espresso that he would not advise vaccination for his patients, adding,
"This virus is not aggressive and there is no reason to force individuals to get immunized against the virus."
PRESS TV
Related Links:
*
Doctors, Healthcare Workers And Patients Refusing Swine Flu Vaccine In Britain
Nigel Praities, PULSE
*
Why This Doctor Questions Flu Vaccination
Dr Damien Downing MD, Orthomolecular Medicine News Service
*
Switzerland Refuses GSK's Pandemrix Swine Flu Vaccine For Pregnant Women, Children And Elderly
Editorial, The Flu Case

 
3.  
American Doctors Rejecting Swine Flu Vaccine And Spray

Some doctors are just saying no to the swine flu vaccine.
"My feeling is that this is all being over-hyped," said Laurence J. Murphy, a pediatrician in Burke who also will not inoculate his patients. "Most people who get this virus do beautifully. I believe the vaccine hasn't been tested enough. I just think the benefit of it at this point is not outweighed by the possible risk." Bob Sears, of Orange County, California, said: "What bothers me is pretty much every doctor in the country is jumping on the bandwagon and saying, 'This vaccine is completely safe' -- even for the pregnant woman and the unborn baby, but they can't give you a single study that backs up that statement." Dr Meryl Nass MD commented: "In this situation, when there's very little data, I don't think people -- and children in particular -- should be asked to bear the burden of being experimental subjects."
Rob Stein & Michael Laris, The Washington Post

4.  
American People Decline Swine Flu Vaccine

What if they threw a mass vaccination . . . and nobody came?

A nationwide CNN poll taken last month found that only 49 percent of those asked consider the H1N1 vaccine safe. And according to an L.A. Times/USC poll released on Friday, a majority of registered voters in California are planning to skip the H1N1 shot altogether. Barbara Loe Fisher, co-founder of the National Vaccine Information Center says we just don't know enough about the H1N1 vaccine to make an informed decision.
"What's the true nature of this outbreak?" she asked. "What are the true risks of the vaccine for different people? I don't think we have all those answers." Journalist Michael Specter said: "Pharmaceutical companies have lied to the American public in the past, so shouldn't we be skeptical?"
Tracy Smith, CBS News

 
5.  
The Promise And Problems Of Vaccine Adjuvants

Dr Meryl Nass, MD
A well-researched piece on adjuvants from CIDRAP (Oct. 30, 2007), by Maryn McKenna. Excerpts: "There is currently no regulatory pathway by which adjuvants may be submitted for approval as products by themselves — or may be paired with a separately manufactured antigen, perhaps one produced by another company.
"I have heard a lot of people say they expect problems with adjuvanted vaccines," said Hedwig Kresse, an associate analyst for infectious diseases with the British-based market analysts Datamonitor. "It is a technology that definitely has some potential, but there are a lot of issues that need to be addressed first."
Dr Meryl Nass, MD

READ THE NEWS ON ONE CLICK
http://www.theoneclickgroup.co.uk